Eric is a highly accomplished and passionate leader with 30 years of experience in medical sales and marketing with a particular focus on diagnostics. As Chief Executive Officer of Kiyatec Inc., he demonstrates exceptional leadership in the functional oncology space, overseeing sales, marketing, and operations. Eric has a proven track record of success, evident in his ability to secure fundraising for ongoing initiatives, rebrand products for patient-focused launches, and strategically restructure organizations for optimal performance.

In his previous roles, including Senior Vice President at LumiraDx and Chief Commercial Officer/GM at Lumos Diagnostics, Eric showcased his expertise in expanding market share, establishing international distribution networks, and driving significant revenue growth. His work at Astute Medical, Singulex, and Biosite Corporation further highlights his ability to lead successful product launches, secure funding rounds, and achieve remarkable growth in the highly competitive medical diagnostics industry.

Eric’s strategic foresight, fundraising prowess, and unwavering commitment to bringing potentially lifesaving diagnostics to market make him a driving force in advancing healthcare innovation and improving patient outcomes.

Dr. Tessa DesRochers is responsible for managing all research and development within Kiyatec, including all government contracts and grants, external collaborations, and internal preclinical and clinical assay development. Before joining the company, Tessa was in the Department of Biomedical Engineering at Tufts University where she developed bioengineered 3D models of human kidney tissue and breast cancer with applications in the areas of nephrotoxicology, disease modeling, and infectious disease. She has published numerous peer-reviewed articles in the area of tissue engineering and disease applications, has presented a number of abstracts at multiple scientific meetings, and serves as an ad hoc reviewer for several peer-reviewed journals.

As a “military brat,” Tessa grew up in numerous locations, including California, England, and Ohio, before her family settled in New Hampshire. She attended the University of New Hampshire where she graduated cum laude with a BS in biochemistry. She received her PhD from Tufts University’s Sackler School of Graduate Biomedical Sciences in cell, molecular, and developmental biology where her thesis focused upon epigenetic gene regulation in a 3D model of human skin. Her postdoctoral training included a year at Children’s Hospital in Boston and subsequent training in the lab of Dr. David Kaplan at Tufts University. Tessa is committed to the development of 3D tissues as better models of human development and disease.

As Vice President of Operations for Kiyatec, Melissa Rayner oversees laboratory and facility operations as well as market access and reimbursement. With an impressive career spanning nearly 30 years, Melissa brings extensive expertise in research, including 19 years focused on plant genetics, molecular genetics, and human genetics along with 9 years of oncology laboratory management experience. She is also a contributing author for numerous peer-reviewed articles in the fields of hereditary diseases and oncology.

In her previous roles, including Director of Laboratory Operations at Selah Genomics and the John P. Hussman Institute for Human Genomics, Melissa has demonstrated a remarkable track record. Her accomplishments include obtaining CLIA, CAP, and state laboratory certifications, managing facility relocations and renovations, and ensuring successful medical billing for clinical assays.

A proud graduate of the North Carolina School of Science and Mathematics, Melissa also graduated magna cum laude with a BS in biology from North Carolina Central University and received her MS in biotechnology regulatory affairs at the University of Maryland Global Campus. Since 2014, she has held certifications as a technologist in molecular biology from the American Society for Clinical Pathology and a molecular pathology technologist license from the State of Florida Division of Medical Quality Assurance. Melissa’s commitment to excellence and her extensive experience make her a valuable asset to the Kiyatec team.

Scott Isacksen is an accomplished strategist and sales leader with three decades of experience in effective business development, growth, and team leadership. In his current role as Vice President, Sales, Scott is leveraging his business acumen and knack for building and empowering high-performing teams to solidify Kiyatec’s reputation as a leader in functional precision oncology. And with his talent for shaping comprehensive commercial infrastructures, he’s perfectly positioned to shepherd Kiyatec toward a future of lasting success.

Throughout his career, Scott has consistently identified new business opportunities, devised market strategies, and cultivated enduring stakeholder relationships. In his most recent role as Senior Sales Director at Myovant Sciences, he played a crucial role in building the initial sales team and launching a novel prostate cancer treatment. Scott’s wealth of experience in launching and growing startups, along with his successful track record of bringing over 20 products to market, has firmly established him as an influential and dynamic leader. With his deep understanding of the pharmaceutical, biotech, and diagnostic landscape, he continues to make a significant impact by driving innovation, accelerating growth, and reshaping the trajectory of the organizations he collaborates with.